Cash Flow Statement

Amortizatization of Intangibles Cash from Financing Activities Cash from Operations Change in Accured Expenses Change in Cash Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Other Working Capital Changes Other financing activities Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Ratios

Kairos Pharma (KAPA) Shares Issued (2025)

Kairos Pharma's Shares Issued history spans 1 years, with the latest figure at $3.1 million for Q1 2025.